ELDICOR
Live / Applied — Second extension granted (statement of use) (as of 22 Oct 2025)
What this means for you
Not registered yet, but its 12 Feb 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98402856
- Mark type
- Stylized text
- Filed
- 12 Feb 2024
- Published for opposition
- 08 Oct 2024
- Attorney of record
- Michael A. Marrero
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention of high cholesterol; Pharmaceutical preparations for the treatment of high cholesterol
Owner
- LIB THERAPEUTICS, INC., CINCINNATI, OH, US
- LIB Therapeutics, LLC, Cincinnati, OH, US
- LIB Therapeutics, LLC, Cincinnati, OH, US
Prosecution history
- 23 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Oct 2025 — SOU EXTENSION 2 GRANTED
- 22 Oct 2025 — SOU EXTENSION 2 FILED
- 22 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 20 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Mar 2025 — SOU EXTENSION 1 GRANTED
- 19 Mar 2025 — SOU EXTENSION 1 FILED
- 19 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Dec 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 19 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Oct 2024 — PUBLISHED FOR OPPOSITION
- 18 Sept 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 Sept 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Sept 2024 — ASSIGNED TO EXAMINER